BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26748932)

  • 1. Prognostic Factors for Chronic Lymphocytic Leukemia.
    Chen C; Puvvada S
    Curr Hematol Malig Rep; 2016 Feb; 11(1):37-42. PubMed ID: 26748932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic markers in chronic lymphocytic leukaemia.
    Hamblin TJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
    Xu W; Cao X; Miao KR; Qiao C; Wu YJ; Liu Q; Fan L; Li JY
    Int J Hematol; 2009 Sep; 90(2):205-211. PubMed ID: 19629630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
    Amaya-Chanaga CI; Rassenti LZ
    Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.
    Siddon AJ; Rinder HM;
    Am J Clin Pathol; 2013 Jun; 139(6):708-12. PubMed ID: 23690112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
    Parikh SA; Shanafelt TD
    Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
    Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
    Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
    Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
    Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia.
    Xu W; Wang YH; Fan L; Fang C; Zhu DX; Wang DM; Qiao C; Wu YJ; Li JY
    Leuk Res; 2011 Aug; 35(8):1060-5. PubMed ID: 21208658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center.
    Falchi L; Keating MJ; Wang X; Coombs CC; Lanasa MC; Strom S; Wierda WG; Ferrajoli A
    Cancer; 2013 Sep; 119(17):3177-85. PubMed ID: 24022787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in chronic lymphocytic leukemia.
    Vyas N; Hassan A
    Indian J Cancer; 2012; 49(1):137-43. PubMed ID: 22842181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New prognostic markers in chronic lymphocytic leukemia.
    Moreno C; Montserrat E
    Blood Rev; 2008 Jul; 22(4):211-9. PubMed ID: 18448218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
    Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
    J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.